
Urgent
Health·6/11/2026AI summary
FDA Warns of Kidney Risks Linked to GSK's Alli Weight Loss Pill
US regulators are warning consumers about potential kidney problems linked to GSK's Alli weight loss pill. The FDA identified 12 cases of kidney complications and advises those with kidney history to consult a doctor.
T
The Independent World
